具有抗瘤活性的强效和选择性IL-4抑制剂
bioRxiv : the preprint server for biology
|February 12, 2026
概括
针对INTERLEUKIN-4 (IL-4) 的小分子抑制剂在治疗免疫媒介疾病方面表现有前途. 在临床前模型中,优化的类似物显示出强有力的和选择性的IL-4抑制,导致显著的瘤抑制和改善的生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 洲际蛋白-4 (IL-4) 是一种调节免疫反应的关键细胞因子,其失调的信号传递与癌症和自身免疫等疾病有关.
- 抗IL-4受体α (IL-4Rα) 抗体dupilumab强调IL-4信号作为治疗点.
- 此前发现了Nico-52,这是第一个可溶性IL-4的小分子抑制剂.
研究的目的:
- 为了确定Nico-52脚手架的结构-活性关系 (SAR),以提高功效和选择性.
- 为了评估小分子IL-4抑制的in vivo抗瘤潜力.
- 评估小分子细胞因子抑制剂对IL-4介导疾病的治疗前景.
主要方法:
- 在Nico-52支架上进行结构-活性关系研究,重点关注p-基基的修改.
- 热转移测定和HEK蓝色IL-4/IL-13记者测定以评估结合选择性和抑制功效.
- 在体外ADME/T剖析和体内研究中,在突变性小鼠瘤模型中进行.
主要成果:
- 具有结构修改的类似物实现了亚微分子到两位数纳米分子强度.
- 强效的类似物证明了对IL-4的选择性结合和对IL-4的强烈抑制,而不是IL-13.
- 类同类物抑制了I型和II型IL-4受体信号传递,显示出良好的ADME/T特性.
- 在体内研究显示显著的瘤抑制,改变了巨细胞两极分化,并改善了类同类的生存率.
结论:
- 针对IL-4的小分子抑制剂可以优化为强效和选择性抑制.
- 小分子IL-4抑制显示出显著的抗瘤疗效和改善生存的潜力.
- 这些发现支持开发小分子细胞因子抑制剂来治疗IL-4驱动疾病.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
693
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
693
T Cell Activation and Clonal Selection
16.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.3K
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
What is Natural Selection?
129.8K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.8K
Antibiotic Selection
60.2K
Overview
60.2K
Types of Selection
45.3K
Natural selection influences the frequencies of particular alleles and phenotypes within populations in several different ways. Primarily, natural selection can be directional, stabilizing, or disruptive. Directional selection favors one extreme trait and shifts the population towards that phenotype while selecting against individuals displaying alternate traits. Stabilizing selection favors an intermediate trait with a narrow range of variation. Deviation from the optimal phenotype towards an...
45.3K


